Related references
Note: Only part of the references are listed.Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma: Updated results from the FAST trial.
Ugur Sahin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
Eva-Maria Birkman et al.
VIRCHOWS ARCHIV (2018)
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
Ugur Sahin et al.
EUROPEAN JOURNAL OF CANCER (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer
Yang Shu et al.
NATURE COMMUNICATIONS (2018)
RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer
Hanna Yang et al.
NATURE COMMUNICATIONS (2018)
Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma
Gayathri Anandappa et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Prabhsimranjot Singh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Expression of claudin 1, claudin 4, and claudin 7 in colorectal cancer and its relation with CLDN DNA methylation patterns
Victoria Hahn-Stromberg et al.
TUMOR BIOLOGY (2017)
Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization
Micaela Mathiak et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Tight junction strand formation by claudin-10 isoforms and claudin-10a/-10b chimeras
Susanne Milatz et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
New agents on the horizon in gastric cancer
F. Lordick et al.
ANNALS OF ONCOLOGY (2017)
Cancer of the Esophagus and Esophagogastric Junction-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Thomas W. Rice et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration
Daisaku Ashikari et al.
CANCER SCIENCE (2017)
High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications
Sangjeong Ahn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Sarcina: the eyes see what the mind knows
Federica Grillo et al.
HUMAN PATHOLOGY (2016)
CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells
Yaxiong Guo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac
Yafang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
Federica Grillo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer
Keisuke Matsusaka et al.
ONCOTARGET (2016)
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases
Rocco Cappellesso et al.
HUMAN PATHOLOGY (2015)
Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelelial Integrity
Fei Yao et al.
CELL REPORTS (2015)
Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
Sara K. Walesch et al.
CANCERS (2015)
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Irene Gullo et al.
ENDOSCOPY INTERNATIONAL OPEN (2015)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Tricellulin Expression and its Prognostic Significance in Primary Liver Carcinomas
Aron Somoracz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer
Kyong-Hwa Jun et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples
Federica Grillo et al.
TRANSLATIONAL ONCOLOGY (2013)
Deficiency of Claudin-18 Causes Paracellular H+ Leakage, Up-regulation of Interleukin-1β, and Atrophic Gastritis in Mice
Daisuke Hayashi et al.
GASTROENTEROLOGY (2012)
Early HER2 dysregulation in gastric and oesophageal carcinogenesis
Matteo Fassan et al.
HISTOPATHOLOGY (2012)
PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells
Amanda D. French et al.
International Journal of Medical Sciences (2012)
Epstein-Barr Virus-associated Gastric Carcinoma: A Distinct Carcinoma of Gastric Phenotype by Claudin Expression Profiling
Aya Shinozaki et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Structure and function of claudins
Gerd Krause et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance
Biljana Jovov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype
Y Sanada et al.
JOURNAL OF PATHOLOGY (2006)
Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas
C Lódi et al.
MODERN PATHOLOGY (2006)
Claudin expression in Barrett's esophagus and adenocarcinoma
H Gyorffy et al.
VIRCHOWS ARCHIV (2005)
Share Paper
